Bemærk: Kan ikke leveres før jul.
Forventes på lager: 18-12-2020
This book provides guidance on selecting specific benefit–risk (B–R) frameworks and quantitative methods. Leading experts from industry, regulatory agencies, and academia present practical examples, lessons learned, and best practices that illustrate how to conduct structured B–R assessment in clinical development and regulatory submission. The
| Forlag | Taylor & Francis Ltd |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgivelsesdato | 18-12-2020 |
| Første udgivelsesår | 2020 |
| Serie | Chapman & Hall/CRC Biostatistics Series |
| Fagredaktør | Qi Jiang, Weili He |
| Originalsprog | United Kingdom |
| Sideantal | 296 |
| Indbinding | Paperback / softback |
| Forlag | Taylor & Francis Ltd |
| Sideoplysninger | 296 pages |
| Mål | 254 x 178 |
| ISBN-13 / EAN-13 | 9780367737085 |